José E Manautou Selected Research

1- O- (2- ((2',6'- dichlorophenyl)amino)phenylacetyl)glucopyranuronic acid

7/2015

Multidrug Resistance-Associated Protein 3 Plays an Important Role in Protection against Acute Toxicity of Diclofenac.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José E Manautou Research Topics

Disease

7	Breast Neoplasms (Breast Cancer) 10/2019 - 02/2006
4	Drug-Related Side Effects and Adverse Reactions 01/2022 - 07/2015
4	Acute Liver Failure (Fulminant Hepatic Failure) 01/2022 - 10/2007
4	Necrosis 01/2016 - 01/2006
2	Obesity 01/2021 - 01/2008
2	Neoplasms (Cancer) 01/2016 - 06/2007
2	Acute Kidney Injury (Acute Renal Failure) 05/2014 - 09/2008
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 10/2007 - 03/2006
2	Disease Progression 06/2007 - 03/2006
2	Cholestasis 01/2006 - 01/2006
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2022
1	Rare Diseases (Rare Disease) 01/2021
1	Hypercholesterolemia 01/2021
1	Glucose Intolerance 01/2021
1	Gliosis 12/2019
1	Hepatic Encephalopathy 12/2019
1	Fatty Liver 04/2016
1	Inflammation (Inflammations) 04/2016
1	Non-alcoholic Fatty Liver Disease 04/2016
1	Pain (Aches) 07/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2014
1	Type 2 Diabetes Mellitus (MODY) 01/2008
1	Liver Failure 10/2007

Drug/Important Bio-Agent (IBA)

9	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2022 - 01/2006
8	Proteins (Proteins, Gene)FDA Link 10/2019 - 02/2006
7	Multidrug Resistance-Associated ProteinsIBA 01/2021 - 02/2006
6	Messenger RNA (mRNA)IBA 04/2016 - 05/2006
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2008
3	quinone (benzoquinone)IBA 04/2016 - 01/2006
3	Peptides (Polypeptides)IBA 09/2008 - 02/2006
3	AnionsIBA 09/2008 - 01/2006
2	Biological ProductsIBA 01/2022 - 07/2015
2	Diclofenac (SR 38)FDA LinkGeneric 10/2019 - 07/2015
2	Cisplatin (Platino)FDA LinkGeneric 05/2014 - 09/2008
2	CationsIBA 09/2008 - 01/2008
2	Taurocholic Acid (Sodium Taurocholate)IBA 01/2008 - 02/2006
2	EnzymesIBA 01/2008 - 03/2006
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2008 - 10/2007
2	NAD (NADH)IBA 03/2006 - 01/2006
2	Oxidoreductases (Dehydrogenase)IBA 03/2006 - 01/2006
1	Antisense OligonucleotidesIBA 01/2022
1	casimersenIBA 01/2022
1	ALN-PCSIBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	LeptinIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2019
1	TeaIBA 04/2016
1	NADP (NADPH)IBA 04/2016
1	Malondialdehyde (Propanedial)IBA 04/2016
1	LipidsIBA 04/2016
1	PolymersIBA 01/2016
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2016
1	1- O- (2- ((2',6'- dichlorophenyl)amino)phenylacetyl)glucopyranuronic acidIBA 07/2015
1	Galectin 3 (LGALS3)IBA 01/2014
1	IronIBA 09/2008
1	ferric nitrilotriacetateIBA 09/2008
1	Subfamily B ATP Binding Cassette TransporterIBA 09/2008
1	Carrier Proteins (Binding Protein)IBA 09/2008
1	XenobioticsIBA 09/2008
1	BuffersIBA 01/2008
1	Citric Acid (Citrate)FDA LinkGeneric 01/2008
1	dimethylethylsilylimidazoleIBA 01/2008
1	Streptozocin (Streptozotocin)FDA Link 01/2008
1	DNA (Deoxyribonucleic Acid)IBA 10/2007
1	AntioxidantsIBA 06/2007
1	Benzo(a)pyreneIBA 06/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2007
1	Carbon Tetrachloride (Tetrachloromethane)IBA 02/2006
1	Coloring Agents (Dyes)IBA 01/2006

Therapy/Procedure

2	Therapeutics 01/2021 - 06/2007